MedTrace Logo

Glycemic Control Before, During and After the 2016 Paris Marathon

NCT04926298 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2025-02-05

No results posted yet for this study

Summary

This is an observational mono-centric retrospective study carried out at the University Hospital of Brest The main objective of this study is to assess the glycemic control before, during and after the 2016 Paris Marathon in patients with type 1 diabetes using continuous glucose measurement (CGM) by DEXCOM sensor.

Conditions

  • Marathon
  • Physical Activity
  • Type 1 Diabetes Mellitus
  • Education
  • Hypoglycemia

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-15
Primary Completion
2020-09-15
Completion
2020-12-06

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04926298 on ClinicalTrials.gov